Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Preeti Lal"'
Autor:
Preeti Lal, Jina Lee, Dhwani Haria, Jayamary Divya Ravichandar, Jill Desnoyer, Sabina Lau, Erica Rutherford, Karim Dabbagh, Helena Kiefel
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/9b777755354a4abaa12700cd0b57a9a6
Autor:
Aarthi Balasubramanyam, Sebastian Froehler, Ralph Floegel, H. Jost Achenbach, Rainer Krügel, Alexander F. Lovejoy, Lijing Yao, Frederike Fuhlbrück, Li Tai Fang, Hans-Peter Adams, Nalin Tikoo, John Jiang, John F. Palma, Stephanie J. Yaung, Preeti Lal
Publikováno v:
The Journal of Molecular Diagnostics. 22:228-235
Molecular biomarkers hold promise for personalization of cancer treatment. However, a typical tumor biopsy may be difficult to acquire and may not capture genetic variations within or across tumors. Given these limitations, tumor genotyping using nex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d541abb13417cacfb5cdd9f883c288ab
https://doi.org/10.1016/j.jmoldx.2019.10.013
https://doi.org/10.1016/j.jmoldx.2019.10.013
Autor:
Michelle Lin, Archana S. Nagaraja, Dhwani Haria, Yuliya Katlinskaya, Divya Ravichandar, Preston Williams, Roberta Hannibal, Todd Z. DeSantis, Bum-Yeol Hwang, Michi Wilcoxon, Toshi Takeuchi, Karim Dabbagh, Preeti Lal, Helena Kiefel
Publikováno v:
Molecular Cancer Therapeutics. 20:P260-P260
The gut microbiome is an important determinant for the success of anti-tumor therapies including chemotherapeutics and anti-checkpoint inhibitors. In this study we wanted to leverage Second Genome’s large and curated microbiome database coupled wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::545aad170f8527476cf17271b82f56e2
https://doi.org/10.1158/1535-7163.targ-21-p260
https://doi.org/10.1158/1535-7163.targ-21-p260
Autor:
Karim Dabbagh, Erica Rutherford, Preeti Lal, Sabina Lau, Jina Lee, Jayamary Divya Ravichandar, Jill Desnoyer, Helena Kiefel, Dhwani Haria
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundDespite the unprecedented clinical success of immune checkpoint therapy (ICI) in many cancers there is still a large unmet need since many patients have an inadequate response. Fecal Matter Transplant from anti-PD-1 responding subjects into
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27ed9a87e20e7efe6f80a4d77ea4a433
https://doi.org/10.1136/jitc-2021-sitc2021.569
https://doi.org/10.1136/jitc-2021-sitc2021.569
Autor:
Sophe Ap, Victoria C. Smith, David Gossage, Preeti Lal, Yan Xin, Guang Chen, John S. Sundy, Blanka Cieslarová, Hao Zheng
Publikováno v:
Clinical therapeutics. 40(1)
Andecaliximab (GS-5745) is a highly selective monoclonal antibody against matrix metalloproteinase-9 (MMP9), a proteolytic enzyme implicated in the pathogenesis of rheumatoid arthritis (RA). This study assessed the safety and pharmacokinetic (PK) par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b89b3710de33ea9a7d880ed7e2781a2
https://pubmed.ncbi.nlm.nih.gov/29287749
https://pubmed.ncbi.nlm.nih.gov/29287749
Autor:
Gregg J. Silverman, Timothy W. Behrens, John G. Monroe, Preeti Lal, Ariella Kelman, Zheng Su, Sergio Schwartzman, Michael J. Townsend, Greg Spaniolo, Simon Read, Cecile T.J. Holweg
Publikováno v:
Arthritis & Rheumatism. 63:3681-3691
Objective Rituximab significantly improves the signs and symptoms of rheumatoid arthritis (RA) and slows the progression of joint damage. The aim of this study was to identify clinical characteristics and biomarkers that identify patients with RA in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::690d18988232d8bc156b0488b2aca34e
https://doi.org/10.1002/art.30596
https://doi.org/10.1002/art.30596
Autor:
Frank Marusch, Stephanie J. Yaung, Sylvie McNamara, Thomas Steinmüller, Preeti Lal, Rainer Kube, Michael Heise, Li Tai Fang, Matthias Pross, René Mantke, Sebastian Fröhler, John Lee, Frederike Fuhlbrück, A. Rosenthal, Corinna Wöstmann, Lijing Yao, John F. Palma, Hans-Peter Adams
Publikováno v:
Cancer Research. 78:2960-2960
Introduction: Determining mutations in plasma (cfDNA) is a noninvasive method of profiling tumor genomic alterations. In this study, concordance of SNVs using NGS between matched plasma and formalin-fixed, paraffin-embedded (FFPE) tissue samples was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::344bef19d813dfeea9c06ae2f5ff84ac
https://doi.org/10.1158/1538-7445.am2018-2960
https://doi.org/10.1158/1538-7445.am2018-2960
Autor:
John F. Palma, B. Hinzmann, John Lee, A. Rosenthal, Li Tai Fang, Hugo Y. K. Lam, Lijing Yao, Preeti Lal, Alex Lovejoy
Publikováno v:
Cancer Research. 78:5293-5293
Tumor-specific molecular profiling by next-generation sequencing (NGS) from tissue or blood (liquid biopsy) can have a tremendous potential to guide personalized healthcare for cancer treatments. However, based on the current clinical practices1, oft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47740b1b9707e79c3b98aae33137b376
https://doi.org/10.1158/1538-7445.am2018-5293
https://doi.org/10.1158/1538-7445.am2018-5293
Autor:
Patricia A. Uber, Daniel F. Pauly, Russell Dedrick, Mandeep R. Mehra, Srinivas Murali, Michael G. Walker, Howard J. Eisen, Jon A. Kobashigawa, Tod M. Klingler, Randall C. Starling, Preeti Lal, Steven Rosenberg, Mario C. Deng, Kenneth C. Fang, Adriana Zeevi
Publikováno v:
The Journal of Heart and Lung Transplantation. 27:297-301
Background We have previously demonstrated that a peripheral blood transcriptional profile using 11 distinct genes predicts onset of cardiac allograft rejection weeks to months prior to the actual event. Methods In this analysis, we ascertained the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5783eca32b489cc0a9d260678b6bca39
https://doi.org/10.1016/j.healun.2007.11.578
https://doi.org/10.1016/j.healun.2007.11.578
Publikováno v:
IOP Conference Series: Materials Science and Engineering. 263:052033
In this paper, we have analysed and studied the handoff mechanism in Long Term Evaluation (LTE) network. A LTE network has been defined with a set number of macro-cells, micro-cells and mobile devices. In this handoff mechanism distance and speed has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c40ec0327c6515daa5693951b1db442
https://doi.org/10.1088/1757-899x/263/5/052033
https://doi.org/10.1088/1757-899x/263/5/052033